The compound of the formula or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein: R 1 is independently selected from: phenyl and a 5- to 6-membered heteroaryl comprising carbon atoms and 1-4 heteroatoms selected from N, NR b, O, and S p; wherein said phenyl and heteroaryl are substituted with 0-4 R 5; L 1 is independently -CH 2 CH 2 -, -CH 2 OCH 2 -, -CH 2 O- or -OCH 2 -; L 2 is independently a bond or -CH 2 -; R 2, at each occurrence, is independently selected from: halogen, C 1-6 alkyl substituted with 0-1 R a, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 haloalkyl, and C 1-4 haloalkoxy; R 3 and R 4, at each occurrence, are independently selected from the group consisting of H, halogen, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl; R 5 at each occurrence, is independently selected from: halogen, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, C 1-6 haloalkyl, C 1-6 haloalkoxy, -O-C 2-6 alkenyl, SO 2 (C 1-4 alkyl), and - 0-1 -(CH 2) 0-2 -R 6; alternatively, two R 5 groups, when they are attached to two adjacent carbon atoms and together with the carbon atoms to which they are attached, combine to form a 5- to 6-membered carbocyclic or heterocyclic ring comprising carbon atoms and 0-3 heteroatoms selected from N, NR b, O, and S p; wherein said heterocycle is substituted with 0-2 R c; R 6 is independently selected from: C 3-6 carbocycle and a 5- to 6-membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, NR b, O, and S; wherein said carbocycle and heterocycle are substituted with 0-3 R c; R a, at each occurrence, is independently selected from: C 1-4 alkoxy and C(=O)H; R b, at each occurrence, is independently selected from: H, C 1-4 alkyl, and -(CH 2) 0-2 -phenyl; R c, at each occurrence, is independently selected from: halogen, C 1-6 alkyl, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 haloalkyl, C 1-4 haloalkoxy, CO 2 (C 1-4 alkyl), and COPh; m is independently 0, 1, or 2; and p is, independently at each occurrence, selected from 0, 1, and 2. R 1 is independently selected from: phenyl and a 5- to 6-membered heteroaryl comprising carbon atoms and 1-4 heteroatoms selected from N, NR b, O, and S p; wherein said phenyl and heteroaryl are substituted with 0-4 R 5; L 1 is independently -CH 2 CH 2 -, -CH 2 OCH 2 -, -CH 2 O- or -OCH 2 -; L 2 is independently a bond or -CH 2 -; R 2, at each occurrence, is independently selected from: halogen, C 1-6 alkyl substituted with 0-1 R a, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 haloalkyl, and C 1-4 haloalkoxy; R 3 and R 4, at each occurrence, are independently selected from the group consisting of H, halogen, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl; R 5 at each occurrence, is independently selected from: halogen, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, C 1-6 haloalkyl, C 1-6 haloalkoxy, -O-C 2-6 alkenyl, SO 2 (C 1-4 alkyl), and - 0-1 -(CH 2) 0-2 -R 6; alternatively, two R 5 groups, when they are attached to two adjacent carbon atoms and together with the carbon atoms to which they are attached, combine to form a 5- to 6-membered carbocyclic or heterocyclic ring comprising carbon atoms and 0-3 heteroatoms selected from N, NR b, O, and S p; wherein said heterocycle is substituted with 0-2 R c; R 6 is independently selected from: C 3-6 carbocycle and a 5- to 6-membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, NR b, O, and S; wherein said carbocycle and heterocycle are substituted with 0-3 R c; R a, at each occurrence, is independently selected from: C 1-4 alkoxy and C(=O)H; R b, at each occurrence, is independently selected from: H, C 1-4 alkyl, and -(CH 2) 0-2 -phenyl; R c, at each occurrence, is independently selected from: halogen, C 1-6 alkyl, C 1-4 alkoxy, C 1-4 alkylthio, C 1-4 haloalkyl, C 1-4 haloalkoxy, CO 2 (C 1-4 alkyl), and COPh; m is independently 0, 1, or 2; and p is, independently at each occurrence, selected from 0, 1, and 2.